Alexandra Kropotova is CHIEF MEDICAL OFFICER of SAB Biotherapeutics, Inc.. Currently has a direct ownership of 48,428 shares of SABS, which is worth approximately $102,667. The most recent transaction as insider was on Dec 18, 2024, when has been sold 9,072 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.4K
82.39% 3M change
82.39% 12M change
Total Value Held $102,667

Alexandra Kropotova Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 18 2024
SELL
Payment of exercise price or tax liability
-
9,072 Reduced 15.78%
48,428 Common Stock
Mar 14 2023
BUY
Grant, award, or other acquisition
-
275,000 Added 50.0%
275,000 Common Stock
Jun 06 2022
BUY
Grant, award, or other acquisition
-
300,000 Added 50.0%
300,000 Common Stock

Also insider at

IBIO
iBio, Inc. Healthcare
AK

Alexandra Kropotova

CHIEF MEDICAL OFFICER
Sioux Falls, SD

Track Institutional and Insider Activities on SABS

Follow SAB Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SABS shares.

Notify only if

Insider Trading

Get notified when an Sab Biotherapeutics, Inc. insider buys or sells SABS shares.

Notify only if

News

Receive news related to SAB Biotherapeutics, Inc.

Track Activities on SABS